BC
BioCardia, Inc.
BCDA · NASDAQ
$1.10 -0.97% (-$0.01)
1M +18.01%
Market Cap $16.4M
P/E Ratio -
Div. Yield -
ROE 569.36%
Piotroski F-Score Weak
1/9Valuation
24 /100
Expensive P/B 6.06x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 43.23%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 246.91%
ROE 569.36%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.11x
Current ratio 2.09x
Int. coverage N/A
Stability
60 /100
Moderate Beta 0.49x
Rev. volatility 17.92%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BCDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter A. Altman
Employees
17
Headquarters
Sunnyvale
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report